Efficacy of Direct Acting Antivirals (DAA) therapy in patients with recurrent hepatitis C after liver and kidney transplantation: a cross-sectional study
The DAA-based therapeutic regimen was well tolerated and showed significant effectiveness in achieving the virologic response in patients with HCV reinfection after LT or LKT.
Authors
- Seyyed Taher Seyyed Mahmoudi (ORCID: https://orcid.org/0000-0001-6818-3833)
- Abbas Mofidi (ORCID: https://orcid.org/0000-0002-2827-7998)
- Mehdi Kashani (ORCID: https://orcid.org/0000-0001-6868-6481)
- Alireza Sharifi Rayeni
- Masoud Mortezazadeh (ORCID: https://orcid.org/0000-0003-3585-9379)
- Amirhossein Parsaei (ORCID: https://orcid.org/0000-0002-9980-3238)
- Niyousha Shirsalimi (ORCID: https://orcid.org/0000-0002-3337-942X)
- Mohammad M. Karimi (ORCID: https://orcid.org/0000-0001-5017-1252)
- Nooshin Abolghasemi
- Mohammad Ali Azizi Nadian
Institutions
- Hamedan University of Medical Sciences (IR)
- Tabriz University of Medical Sciences (IR)
- Sina Hospital (IR)
- Islamic Azad University Pharmaceutical Sciences Branch (IR)
- Shahid Beheshti University of Medical Sciences (IR)
- Tehran University of Medical Sciences (IR)
- Bogomolets National Medical University (UA)
Publication Details
- Journal
- Frontiers in Medicine
- Published
- 2024-10-09
- DOI
- https://doi.org/10.3389/fmed.2024.1460372
- Citations
- 2
- Primary Topic
- Hepatitis C virus research
- Type
- article
- Field-Weighted Citation Impact
- 0.74
Funders
- Tehran University of Medical Sciences and Health Services